Comparing survival outcomes of gross total resection and subtotal resection with radiotherapy for craniopharyngioma: a meta-analysis

J Surg Res. 2018 Jun:226:131-139. doi: 10.1016/j.jss.2018.01.029. Epub 2018 Feb 22.

Abstract

Background: Recent studies suggest that subtotal resection (STR) followed by radiation therapy (RT) is an appealing alternative to gross total resection (GTR) for craniopharyngioma, but it remains controversial. We conducted a meta-analysis to determine whether GTR is superior to STR with RT for craniopharyngioma.

Materials and methods: A systematic search was performed for articles published until October 2017 in the PubMed, Embase, and Cochrane Central databases. The endpoints of interest are overall survival and progression-free survival. Pooled hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were calculated using a fixed or random-effects model. The data were analyzed using Review Manager 5.3 software.

Results: A total of 744 patients (seven cohort studies) were enrolled for analyses. There were no significant differences between the GTR and STR with RT groups when the authors compared the pooled HRs at the end of the follow-up period. Overall survival (pooled HR = 0.76, 95% CI: 0.46-1.25, P = 0.28) and progression-free survival (pooled HR = 1.52, 95% CI: 0.42-5.44, P = 0.52) were similar between the two groups.

Conclusions: The current meta-analysis suggests that GTR and STR with RT have the similar survival outcomes for craniopharyngioma.

Keywords: Craniopharyngioma; Gross total resection; Meta-analysis; Radiation therapy; Subtotal resection; Survival outcomes.

Publication types

  • Comparative Study
  • Meta-Analysis

MeSH terms

  • Craniopharyngioma / mortality
  • Craniopharyngioma / pathology
  • Craniopharyngioma / therapy*
  • Humans
  • Neurosurgical Procedures / methods*
  • Pituitary Gland / pathology
  • Pituitary Gland / surgery
  • Pituitary Neoplasms / mortality
  • Pituitary Neoplasms / pathology
  • Pituitary Neoplasms / therapy*
  • Progression-Free Survival
  • Radiotherapy, Adjuvant / methods
  • Treatment Outcome